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ABSTRACT Nerve growth factor (NGF) and basic flbro-
blast growth factor (bFGF) stimulate neuronal differentiation,
whereas epidermal growth factor (EGF) promotes only mito-
genic responses in PC12 pheochromocytoma cells. The early
changes in protein synthesis induced by bFGF, NGF, and EGF
in these cells have been determined by two-dimensl PAGE
of [35S~methionine-labeled proteins and computerized image
analysis. The rate of synthesis ofonly 29 proteins (out of 1500
identified) was found to be modulated during the first several
hours of growth factor stimulation. Individually, 12 were
affected by EGF, 23 were affected by bFGF, and 20 were
affected by NGF. Eight of these were regulated by all three
growth factors, while 10 proteins were commonly Induced by
bFGF and NGF, in accordance with the essentially identical
morphological responses induced by these two factors. In
addition, the effects of bFGF and NGF were about equally
divided between increases and decreases in the rate of synthesis
of individual proteins, whereas EGF caused sign tiy more
positive (increased) responses. All proteins modulated by NGF
orFGF alone were negative in their response and those induced
by only EGF were positive. Of particular interest, the rate of
synthesis of two proteins of 55 kDa and pl 5.45 and 5.50 was
dramatically and transiently induced during the first 2 hr of
bFGF and NGF treatment and was not affected by EGF. This
study indicates that all three factors elicit early increases and
decreases in the synthesis of a quite limited number of proteins
and provides molecular evidence for the specificity of a differ-
entiative vs. a proliferative growth factor-induced signaling
pathway in these cells.
Polypeptide growth factors can promote proliferation or
trophic stimulation of responsive cells, by mechanisms that
are still incompletely described. Various transduction signals
have been identified, but the same events are known to be
implicated in mitogenic and differentiative growth factor
signaling pathways, thus obscuring the specificity leading to
the two responses (1, 2).
The rat pheochromocytoma cell line PC12 (3) is induced by
nerve growth factor (NGF) and basic fibroblast growth factor
(bFGF) to reversibly differentiate into cells that morpholog-
ically and biochemically resemble sympathetic neurons (4-
6). This neuronal differentiation ofPC12 cells is accompanied
by a number of rapid biochemical events similar to those
induced by mitogenic agents in other systems, including
changes in phospholipid hydrolysis, protein phosphoryla-
tion, ion fluxes across the plasma membrane, and early gene
expression (for reviews, see refs. 1 and 7-9). In contrast to
bFGF and NGF, epidermal growth factor (EGF) does not
induce differentiation but rather acts as a mitogen for PC12
cells (10). However, most ofthe transduction signals reported
for neurotrophic stimulation have also been described for
EGF (11-21). Thus the molecular specificity of a differenti-
ative vs. a mitogenic signaling pathway in PC12 cells has not
yet been elucidated.
It is of considerable interest that the induction of neurite
outgrowth in PC12 cells by NGF is blocked by inhibitors of
transcription (22). This suggests that ongoing mRNA and
protein synthesis are required for neuronal differentiation.
Previous studies have demonstrated a modulation of protein
synthesis after NGF stimulation. Garrels and Schubert (23)
showed that 72 hr after its addition to the culture medium,
NGF caused only quantitative changes in protein synthesis in
PC12 cells. Approximately 25-30o of the proteins analyzed
by two-dimensional (2D) PAGE was found to be altered in
their rate of synthesis. Since during this period, PC12 cells
have already grown neurites, these changes are clearly at
least partly related to the neuronal phenotype (cytoskeletal
and neurite stabilization). Tiercy and Shooter (24) have
studied the effect ofNGF on protein synthesis during the first
hours of stimulation. These experiments, mostly done using
one-dimensional PAGE, indicate that during this time, NGF
increased the incorporation of [35S]methionine into four
bands with apparent molecular masses of 56, 50, 51.5, and 48
kDa. They also analyzed the proteins synthesized from 7 to
8 hr by 2D PAGE and determined the apparent pI values and
molecular masses of several proteins that are modulated
during this time period. However, modulation of protein
synthesis after bFGF and EGF stimulation and a comparison
to NGF have not been examined, particularly with respect to
proteins affected by two or more growth factors.
To further understand the signaling pathways leading to
PC12 cell proliferation or differentiation, the effect ofbFGF,
NGF, and EGF on the early synthesis of >1500 individual
proteins using 2D PAGE and computerized image analysis
was examined. Our results show an early modulation of
protein synthesis induced by the three growth factors and
provide evidence for specificity of the differentiative vs.
proliferative pathways induced by growth factors in these
cells.
EXPERIMENTAL PROCEDURES
Materials. PC12 cells were obtained from D. Schubert
(Salk Institute, San Diego). NGF-(3 (referred hereafter as
NGF) was prepared by the method ofMobley et aL (25). EGF
was prepared as described (26). bFGF was kindly provided
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by Gary Fox (Amgen, Thousand Oaks, CA). [35S]Methionine
was from ICN.
PC12 Cell Culture. PC12 cells were grown in Dulbecco's
modified Eagle's medium (DMEM) (Flow Laboratories) sup-
plemented with 5% (vol/vol) fetal calf serum (Irvine Scien-
tific), 10%6 (vol/vol) horse serum (Cell Culture Laboratories,
Cleveland), penicillin (100 units/ml), streptomycin (100 .g/
ml), and Fungizone (0.25 pg/ml). Stock cells were grown in
a Belco tissue culture flask (T75 or T150). Cells were fed
every 2 days, passaged weekly, and maintained at 370C in a
humidified atmosphere of 5% C02/95% air.
Cell Stimulation by Growth Factors and Labeling. PC12
cells were resuspended at 105 cells per ml in complete
medium and plated on 35-mm dishes, precoated with rat tail
collagen (27). When 50% confluence was reached, medium
was replaced byDMEM containing 1% horse serum. After 48
hr in this medium, cells were stimulated by growth factors.
The following concentrations were used: NGF, 100 ng/ml;
bFGF, 5 ng/ml; EGF, 10 ng/ml. Cells were labeled for 2 hr
with [35S]methionine at 250 ,uCi/ml. Labeling was performed
immediately after growth factor addition or after 4 hr of
stimulation.
Sample Preparation for Electrophoresis. Samples were pre-
pared as described (28) with some modifications. At the end
of the labeling time, medium was removed, and cells were
rinsed in ice-cold medium and scraped off with a rubber
policeman. After low-speed centrifugation, cells were lysed
with 0.3% SDS/1% 2-mercaptoethanol/4% (vol/vol) LKB
Ampholines, pH 5-7, 5-8, 3-10. Within 30 sec, RNase (0.1
mg/ml) and DNase 1 (0.2 mg/ml) (Worthington) were added
and mixed. After 20 sec, the sample was quickly frozen.
Upon thawing, the samples were diluted 1:2 with 9.5%
(wt/vol) urea/0.8% Nonidet P-40/10% (vol/vol) 2-mercap-
toethanol/2% LKB Ampholines, pH 5-7, 5-8, 3-10, and
mixed for 20 sec. All samples were quickly frozen on dry ice
and stored at -70°C.
The 2D PAGE. Electrophoresis was performed in the Cold
Spring Harbor Laboratory 2D Gel Laboratory Core Facility
as described (28, 29). Briefly, for the first dimension, the
polyacrylamide isoelectric focusing gel contained 9.5M urea,
3% (wt/vol) acrylamide, 0.22% NN'-methylene-bisacryl-
amide, 4% Nonidet P40, and 2% ampholytes (pH 4-8; BDH).
For the second dimension, 10%1 polyacrylamide gels were
used. Typically, 10 4 of sample containing 200,000-300,000
trichloroacetic acid-precipitable cpm was applied to each gel.
After electrophoresis, gels were processed for fluorography
and exposed to Kodak XAR (10 x 12 inch size; 1 inch = 2.54
cm) and three film exposure times (typically, 2, 12, and 50
days) were used.
Computerized Image Analysis. The PDQuest system of 2D
gel image analysis was used to quantify the gel autoradio-
graphic images (Protein Databases, Huntington Station,
NY). Spot intensity, expressed as parts per million (ppm),
represents the amount of radioactivity contained within each
spot relative to the total amount of radioactivity applied to
each gel. The apparent isoelectric point and molecular mass
of each protein were calculated based on spot position
relative to proteins from the REF52 (rat) data base (30).
RESULTS
The synthesis of individual proteins induced by growth
factors in PC12 cells was analyzed by 2D PAGE, after
incorporation of [35S]methionine for 2 hr. Incorporation was
initiated immediately and 4 hr after addition of bFGF, NGF,
and EGF to the culture medium. For each growth factor and
time period studied, three sets of gels were obtained from
three experiments and each gel was exposed to x-ray film for
three different times.
Fig. 1 shows the 2D gel pattern obtained from control PC12
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FIG. 1. Profile of [35S]methionine-labeled proteins of unstimu-
lated (control) PC12 cells in 2D PAGE gels. PC12 cells were
35S-labeled and lysed, and the proteins were analyzed by 2D PAGE.
Molecular masses and pI values were determined from the positions
of proteins observed in the REF52 data base (13). Proteins numbered
1-29 were found to be regulated in their rate of synthesis after
stimulation by growth factors. Characteristics and quantification of
the regulation observed for the numbered proteins aftergrowth factor
treatment are reported in Table 1. The outlined area is enlarged in
Fig. 3. IEF, isoelectric focusing.
cells (i.e., cells unstimulated by growth factor). About 1500
spots are sufficiently intense and well defined to be compared
on the different films. The variation in these spots, induced
by growth factor treatment, has been measured using the
PDQuest system. The reproducibility of this 2D gel analysis
has already been described (31) and the average coefficient of
variation for well-defined spots in 10 replicate gels has been
found to be 21%. This level of reproducibility is exactly
matched in these experiments, as demonstrated by the cal-
culation of the coefficient of variation for 200 well-defined
spots (which were found not to be regulated by any growth
factor used in this study) in all of the gels analyzed. The
results of this statistical analysis (Fig. 2) show that the
coefficients of variation for the nonregulated proteins are
between 12 and 39%, with an average value of21.4%. A 2-fold
variation in spot intensity corresponds to the 95% confidence
level that the spot is growth factor regulated. A variation of
3-fold corresponds to the 99% confidence level (32). As an
additional criteria, the variation in spot intensity had to be
consistent through the three experiments.
On the basis of these data, any change in spot intensity
>2-fold was considered a growth-factor-induced variation.
Proteins numbered 1-29 in Fig. 1 were found to be reproduc-
ibly modulated after growth factor stimulation. The apparent
isoelectric point, relative molecular mass, and quantification
of these spots are shown in Table 1. A summary of the
individual protein changes observed with each growth factor
is displayed in Table 2. Table 3 summarizes the relative
numbers of proteins affected by each growth factor. Most of
the modulations are quantitative rather than qualitative in
Proc. Natl. Acad. Sci. USA 91 (1994)
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FIG. 2. Coefficient of variation for spots unregulated by growth
factor. The coefficient of variation of 226 well-defined spots was
calculated from the analysis of all categories of gels used (control,
EGF for 2 hr and 6 hr, bFGF for 2 hr and 6 hr, and NGF for 2 hr and
6 hr).
nature-i.e., most ofthe corresponding proteins are also found
in the unstimulated control cells, in keeping with the obser-
vations of Garrels and Schubert (23) at longer time points.
Fig. 3 compares the boxed area of the gel presented in Fig.
1 for all three growth factor conditions (2 hr and 6 hr) as well
as the control and is a visual representation of the quantita-
tive data presented in Table 1, which is derived from a
computer image that merges three or more calibrated x-ray
film images into one image. This procedure allows one to
maintain a quantitative relationship between spots that vary
by four or five orders of magnitude in intensity. The montage
(Fig. 3) was composed from the darkest x-ray film exposure,
which was then photographed, printed, and assembled.
These multiple photographic processes lose the grey scale
information that was present in the original film and tend to
present the spots as saturated black spots. Nevertheless, it is
clear that spot 9 is absent in the control and EGF-treated cells
and is strongly induced at the 2-hr points by both bFGF and
NGF. Spot 10 isjust at the limit of detection in the control and
in EGF-treated cells and is strongly induced at the 2-hr points
by both bFGF and NGF. The induction of spots 9 and 10 is
transient and by 4-6 hr spot 9 has returned to control levels
and spot 10 is greatly reduced in intensity.
DISCUSSION
As reported for NGF (10, 24), bFGF and EGF do not
significantly change the overall rate of protein synthesis in
PC12 cells and one-dimensional PAGE did not allow the
reproducible detection of changes in the rate of synthesis of
individual proteins for any of the factors (data not shown).
However, the use of high-resolution 2D PAGE led to the
identification of 29 proteins that are variously regulated
during the first hours of growth factor action. Overall, these
variations are approximately equally distributed between
stimulation and inhibition (14 vs. 15 spots) of synthesis and
this pattern is maintained for bFGF and NGF. In contrast, 9
of the 12 proteins regulated by EGF showed an increase in
their rate of synthesis. Furthermore, all of the proteins
affected by EGF alone were positive in their response while
Table 1. Quantification of the modulation of individual protein synthesis rates
Protein synthesis rate, ppm
Molecular EGF bFGF NGF
Protein mass,
number pI kDa Control 0-2 hr 4-6 hr 0-2 hr 4-6 hr 0-2 hr 4-6 hr
1 5.45 85 746 856 624 22Q 2 847 808
2 6.90 86 336 358 h 372 316 420 310
3 7.10 86 471 416 382 377 2 2 21
4 7.25 86 244 268 210 22 2X 238 198
5 5.20 71 3264 3900 1192 1922 fg1 2991
6 7.10 69 55 64 86 Z2 86 a 74
7 5.05 63 104 130 2a1ufi 2.1 21 22
8 5.45 57 1477 1271 1379 2X 415 602 420
9 5.45 55 ND ND ND 3lu ND 295 ND
10 5.50 55 69 90 60 3250 225 5444 108
11 5.55 51 382 474 384 367 1368 11261
12 7.10 59 328 484 396 377 270 444 ND
13 5.15 40 613 588 428 392 i71 523 1A5
14 7.05 43 342 546 384 812 383 1469 315
15 5.20 39 336 310 2WQ 63.2 2 2X 226
16 5.35 39 484 478 2MQ 212 13 532 132
17 5.90 38 1171 1030 1018 715 2 885 995
18 6.00 39 520 488 472 697 2X 344 489
19 6.15 37 586 684 490 647 .1 476 487
20 7.20 40 448 504 1062 490 325 382 489
21 5.60 35 775 714 M3 562 la 600 M
22 5.10 31 434 434 244 797 1250 720 .1
23 6.20 27 459 436 354 460 388 405 2
24 7.30 34 407 450 380 ND ND 2 16
25 7.45 34 232 230 1h 300 386 253 369
26 5.65 22 782 680 616 740 226 597 la
27 7.25 25 182 164 287 433 264 426
28 7.30 26 186 260 B 255 a 458 228
29 7.35 26 175 185 2 262 221 147 132
[35S]Methionine-labeled proteins obtained from PC12 cells were separated by 2D PAGE and the fluorograms were analyzed using the PDQuest
system. The values have been obtained from control cells and cells stimulated by EGF for 0-2 hr and 4-6 hr, bFGF for 0-2 hr and 4-6 hr, and
NGF for 0-2 hr and 4-6 hr. The molecular mass and pI were determined by the positions of proteins observed in the REF52 data base (13).
Underlined values represent those that differ significantly (P < 0.05) from the control value. ND, not detected.
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Map positions refer to the map positions given in Fig. 1. + or -
indicates direction of effect relative to zero time control (proteins
affected by more than one factor always showed the same direction
of response).
the opposite is true for the proteins affected by NGF orbFGF
alone (Table 2). This striking difference may indicate that
EGF, a mitogenic factor, stimulates the synthesis of proteins
that are concerned with cell growth and division and are
already activated in the transformed PC12 cells. In contrast,
neurotrophic factors may induce neuronal differentiation, in
part, by turning down (or off) the rate of synthesis of crucial
proteins implicated in the mitogenic process. Such a model is
in accordance with the observed down-regulation ofthe EGF
receptor by NGF (10, 33). We have also shown that none of
the proteins for which synthesis is activated by EGF is
inhibited by NGF and bFGF. This could be related to the
transformed character of PC12 cells in which crucial proteins
implicated in mitogenesis are presumably activated prior to
stimulation by growth factors.
Several proteins were found to be regulated by all of the
factors. These proteins had apparent molecular masses of 71
kDa (pI 5.2; spot 5), 63 kDa (pI 5.05; spot 7), 39 kDa (pI 5.2;
spot 15), 39 kDa (pI 5.35; spot 16), 35 kDa (pI 5.6; spot 21),
31 kDa (pI 5.1; spot 22), 25 kDa (pl 7.25; spot 27), and 26 kDa
(pI 7.30; spot 28) (see Table 1). Induction of early gene
transcription has been reported after PC12 stimulation by
Table 3. Summary of proteins affected by growth factors during
2-6 hr of incubation
Direction of
effect, no.
Growth factor No. affected/total no. + -
EGF 12/29 9 3
bFGF 23/29 10 13













FIG. 3. Enlargement of the outlined area in Fig. 1 obtained from
unstimulated cells (A), EGF-stimulated cells at 2 hr (B) and 6 hr (C),
bFGF-stimulated cells at 2 hr (D) and 6 hr (E), and NGF-stimulated
cells at 2 hr (F) and 6 hr (G).
growth factors, as exemplified by increases of myc, fos, jun,
src, and other TIS gene transcripts during the first 2 hr ofboth
NGF and EGF stimulation (11, 13, 15, 34).
Common effects in protein synthesis induced by EGF and
aFGF have been described in cultured rat astroblasts (35).
These authors showed that acidic FGF and EGF modulate
the synthesis of 48 and 44 proteins, respectively, and that 41
of these proteins are commonly regulated by both growth
factors. In rat astroblasts, EGF and acidic FGF have a similar
effect-i.e., both stimulate cell proliferation. In the experi-
ments reported here, only 5 proteins were found to be
commonly regulated by EGF and FGF, which may reflect the
difference between the mitogenic effect of EGF and the
neuronal differentiation induced by bFGF in these cells.
Interestingly, despite the fact that increases in the transcrip-
tion of the /3actin gene have been reported during the first 2
hr ofEGF and NGF stimulation (13), no difference in the rate
of 3-actin synthesis even after 6 hr of stimulation by these
growth factors was observed. However, an increase in
mRNA transcription does not necessarily indicate an in-
crease in protein translation and a concomitant change in the
turnover rate of f3-actin could result in an apparent stability
in its rate of synthesis.
The pattern of protein synthesis induced by the two
neurotrophic growth factors, bFGF and NGF, appears to be
very similar. Only a few proteins, five for bFGF and two for
NGF, are differently modulated by each growth factor (Ta-
bles 1 and 2). These differences could reflect the slight
morphological differences in neuritogenesis induced by
bFGF and NGF. Neurite outgrowth, although initially ap-
pearing similar, has a different time course for each; after
NGF stimulation, neurites continue to elongate and arborize,
but with bFGF, process formation tends to stop after 2-3
days (6, 19). Of the 23 and 20 proteins found regulated by
bFGF and NGF, respectively, 18 proteins are commonly
regulated by both factors. After subtraction of the spots also
regulated by EGF, 10 proteins remain that are specifically
regulated by the two neurotrophic factors that may be
specific for neurodifferentiative signaling. The detection of
such a subset of proteins, specifically modulated by neuro-
trophic factors, clearly demonstrates the specificity of dif-
ferentiative vs. mitogenic signaling pathways.
Although most of the changes observed were quantitative,
one spot was newly and transiently synthesized after stimu-
lation by bFGF and NGF. This spot (number 9) of55 kDa and
pI 5.45 is not present in the gels corresponding to the control
and EGF samples and appears in the bFGF- and NGF-related
Proc. Natl. Acad. Sci. USA 91 (1994)
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gels only during the first 2 hr of growth factor stimulation.
Although spots 9 and 10 are clearly distinct, they may
correspond to the same protein with a different level of
phosphorylation. Thus, protein 9 would be the more heavily
phosphorylated of the two.
The identity of these spots is intriguing. Immunoblots
indicate that they are apparently not Shc (D. Thomas and
R.A.B., unpublished experiments), a protein that has been
identified as being involved in growth factor responses (36,
37). There are, however, also other possible identities for
these proteins, including nuclear protooncogenes (13). How-
ever, the 0- to 2-hr incubation before the first time point may,
in some cases, be too long to see immediate early transient
inductions in growth factor regulation. Indeed, the proteins
identified in this study are probably more likely to represent
primarily secondary transcriptional responses. Ornithine de-
carboxylase, as representative of this group, can also be
excluded because (i) it has a significantly more basic pI (38),
(ii) has a different time course of induction (14, 39), and (iii)
is also induced by EGF (14). Tiercy and Shooter (24) showed
a marked increase in the rate of biosynthesis of two nuclear
56-kDaproteins with pI values of5.7 and 5.8 after 8 hrofNGF
action; bFGF and EGF were not used in this study. Since
these proteins have been detected after 8 hr of NGF action
and their pI values are different, it is unlikely that they
correspond to proteins 9 and 10 identified in this study.
The description of early protein synthesis induced by
bFGF, NGF, and EGF shows a very similar pattern of
modulation for bFGF and NGF, which is somewhat distinct
from the EGF pattern. These observations have allowed the
detection of several rapidly and specifically induced proteins
and provide direct evidence for molecular specificity of
proliferative vs. differentiative signaling pathways. Nonethe-
less, these findings do not specifically address the mecha-
nisms underlying these two responses, and recent evidence
(refs. 40-42 and S. Raffioni and R.A.B., unpublished data)
suggests that the differences may be largely quantitative-
i.e., EGF can stimulate the differentiative pathway but is
unable to maintain the amplitude of the signal for a long
enough time to allow neurite proliferation. In such a model,
mitosis represents the default situation. If so, the differences
observed here would primarily reflect the consequences of
the sustained vs. transient activation of the p21 Ras pathway
(43). The identification of these proteins should help to clarify
further the nature of these differences.
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